Neoplasms Malignant Terminated Phase 1 Trials for Ridaforolimus (DB06233)

Also known as: Neoplasm Malignant / Malignant Tumors / Malignant Tumor / Cancer / Malignant neoplasm NOS / Cancer NOS / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0047288 (Neoplasms Malignant)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01243762A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)Treatment